Shakespeare, Meet Leukemia
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
By Mark Hoffman – Patient
MRD is has been very key in my treatment protocol.
MRD is now key in the treatment decisions for many new targeted therapy.
Fortunately, I was able to get to uMRD. Please watch my video.
html5 video converter by EasyHtml5Video.com v4.0
Mark is 56 yrs. and lives in San Diego with his wife and 3 children. He was diagnosed with CLL is December of 2015. He enjoys biking, back packing and other outdoor activities.
Originally published in The CLL Society Tribune MRD Special Edition.
Related posts
